Abstract
BackgroundHigh glycemic variability (GV) is common in critically ill patients; however, the prevalence and mortality association with early GV in patients with sepsis remains unclear.MethodsThis retrospective cohort study was conducted in a medical intensive care unit (ICU) in central Taiwan. Patients in the ICU with sepsis between January 2014 and December 2015 were included for analysis. All of these patients received protocol-based management, including blood sugar monitoring every 2 h for the first 24 h of ICU admission. Mean amplitude of glycemic excursions (MAGE) and coefficient of variation (CoV) were used to assess GV.ResultsA total of 452 patients (mean age 71.4 ± 14.7 years; 76.7% men) were enrolled for analysis. They were divided into high GV (43.4%, 196/452) and low GV (56.6%, 256/512) groups using MAGE 65 mg/dL as the cut-off point. Patients with high GV tended to have higher HbA1c (6.7 ± 1.8% vs. 5.9 ± 0.9%, p < 0.01) and were more likely to have diabetes mellitus (DM) (50.0% vs. 23.4%, p < 0.01) compared with those in the low GV group. Kaplan–Meier analysis showed that a high GV was associated with increased 30-day mortality (log-rank test, p = 0.018). The association remained strong in the non-DM (log-rank test, p = 0.035), but not in the DM (log-rank test, p = 0.254) group. Multivariate Cox proportional hazard regression analysis identified that high APACHE II score (adjusted hazard ratio (aHR) 1.045, 95% confidence interval (CI) 1.013–1.078), high serum lactate level at 0 h (aHR 1.009, 95% CI 1.003–1.014), having chronic airway disease (aHR 0.478, 95% CI 0.302–0.756), high mean day 1 glucose (aHR 1.008, 95% CI 1.000–1.016), and high MAGE (aHR 1.607, 95% CI 1.008–2.563) were independently associated with increased 30-day mortality. The association with 30-day mortality remained consistent when using CoV to assess GV.ConclusionsWe found that approximately 40% of the septic patients had a high early GV, defined as MAGE > 65 mg/dL. Higher GV within 24 h of ICU admission was independently associated with increased 30-day mortality. These findings highlight the need to monitor GV in septic patients early during an ICU admission.
Highlights
High glycemic variability (GV) is common in critically ill patients; the prevalence and mortality association with early GV in patients with sepsis remains unclear
Patients who died within a few hours after intensive care unit (ICU) admission were excluded given that HbA1C was generally checked on day 2 in the study ICU
These data suggested that a high GV was prevalent in the patients with sepsis and that it was associated with diabetes mellitus (DM) and levels of Glycated hemoglobin (HbA1c)
Summary
High glycemic variability (GV) is common in critically ill patients; the prevalence and mortality association with early GV in patients with sepsis remains unclear. Dysglycemia and optimal glycemic control remain important prognostic factors in patients with sepsis [2, 3]. There is no universal standard for how best to determine GV in patients with sepsis, the number and timing of blood sugar samples required [5]. A previous study using a continuous glucose monitoring system reported that a relatively small number of blood sugar samples in critically ill patients may underestimate GV [8]. We conducted this study with retrospective analysis of patients with sepsis who received protocol-based management with blood sugar monitoring every 2 h after ICU admission. The aim of this study was to investigate the prevalence of high GV and to determine the association between GV and mortality
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have